Topotecan Injection 1 mg (Topotecan (Topotecan Hydrochloride) SOLUTION) 1 MG

Topotecan Injection 1 mg is a cancer treatment solution used for intravenous administration. This medication, manufactured by Sandoz Canada Incorporated, is designed to target specific types of cancer cells.

Strength

1 MG

Pack Size

5X1/3/4ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Topotecan Injection is primarily used in the treatment of various types of cancer. It is often prescribed for ovarian cancer and small cell lung cancer. The medication works by interfering with the growth and spread of cancer cells. Patients may wonder, 'What is Topotecan used for?' This injection is part of a broader category of drugs known as topoisomerase inhibitors, which help to slow or stop the growth of cancer cells.

Side Effects

Common effects of Topotecan Injection may include nausea, vomiting, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary from person to person and may not affect everyone who uses this medication.

Precautions & Warnings

Topotecan Injection should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Topotecan Injection may interact with other medications, including those that affect the immune system or blood cell production. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the effectiveness of this medication.

Frequently Asked Questions

Topotecan Injection is used in the treatment of certain types of cancer, including ovarian cancer and small cell lung cancer.

Topotecan Injection is administered intravenously by a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, and hair loss.

Topotecan Injection may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Topotecan Injection is manufactured by Sandoz Canada Incorporated.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.